Adverse Effect of Cytosine Arabinoside on Disseminated Zoster in a Controlled Trial

New England Journal of Medicine

Volumn 289, Issue 17, 1973, Pages 873-878

  Stevens, David A ^a   Jordan, George W ^a   Waddell, Thomas F ^a   Merigan, Thomas C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; INTERFERON; PLACEBO;

ANTIBODY PRODUCTION; ARTICLE; BLOOD; BLOOD CELL COUNT; CLINICAL TRIAL; COMPLEMENT FIXATION TEST; DRUG EFFECT; HERPES ZOSTER; HODGKIN DISEASE; HUMAN; IMMUNOLOGY; INFUSION; LYMPHOMA; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; VARICELLA ZOSTER VIRUS;

ANTIBODY FORMATION; BLOOD CELL COUNT; CLINICAL TRIALS; COMPLEMENT FIXATION TESTS; CYTARABINE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HODGKIN DISEASE; HUMANS; INFUSIONS, PARENTERAL; INTERFERONS; LYMPHOMA; PLACEBOS; TIME FACTORS;

EID: 0015935871     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197310252891701     Document Type: Article

References (36)

1. Shanbrom E, Miller S, Haar H: Herpes zoster in hematologic neoplasias: some unusual manifestations. Ann Intern Med 53: 523–533, 1960
2. Merselis JG Jr, Kaye D, Hook EW: Disseminated herpes zoster. Arch Intern Med 113: 679–686, 1964
3. Dayan AD, Morgan HG, Hope-Stone HF: Disseminated herpes zoster in the reticuloses. Am J Roentgenol Radium Ther Nucl Med 92: 116–123, 1964
4. Sokal JE, Firat D: Varicella–zoster infection in Hodgkin's disease. Am J Med 39: 452–463, 1965
5. Eckhardt WF Jr, Hebard GW: Severe herpes zoster during corticosteroid therapy: report of a severe attack in a patient with rheumatoid arthritis. Arch Intern Med 108: 594–598, 1961
6. Buthala DA: Cell culture studies on antiviral agents. I. Action of cytosine arabinoside and some comparisons with 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med 115: 69–77, 1964
7. McKelvey EM, Kwaan HC: Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia. Blood 34: 706–711, 1969
8. Hall TC, Wilfert C, Jaffe N: Treatment of varicella–zoster with cytosine arabinoside. Trans Am Assoc Physicians 82: 201–210, 1969
9. Hall T, Wilfert C, Jaffe N: Treatment of varicella–zoster with cytosine arabinoside. Clin Res 17: 470, 1969
10. Plotkin SA, Stetler H: Treatment of congenital cytomegalic inclusion disease with antiviral agents. Antimicrob Agents Chemother 9: 372–379, 1970
11. Juel-Jcnsen BE: Severe generalized primary herpes treated with cytarabinc. Br Med J 2: 154–155, 1970
12. Chow AW, Foerster J, Hryniuk W: Cytosine arabinoside therapy for herpesvirus infections. Antimicrob Agents Chemother 10: 214–217, 1971
13. Prager D, Bruder M, Sawitsky A: Disseminated varicella in a patient with acute myelogenous leukemia: treatment with cytosine arabinoside. J Pediatr 78: 321–323, 1971
14. Neilan BA, Schechter GP: Disseminated herpes zoster: treatment with cytosine arabinoside. Med Ann DC 40: 573–576, 1971
15. Juel-Jensen BE: Cytosine arabinoside and herpes zoster. Lancet 2: 374–375, 1971
16. Foerster J, Hryniuk W: Cytosine arabinoside and herpes zoster. Lancet 2: 712, 1971
17. Stevens DA, Waddell TF, Merigan TC: Effect of cytosine arabinoside on disseminated herpes zoster and vesicle fluid interferon. Ann Intern Med 76: 873, 1972
18. Hryniuk W, Foerster J, Shojania M: Cytarabine for herpesvirus infections. JAMA 219: 715–718, 1972
19. Stevens DA, Merigan TC: Uncertain role of cytosine arabinoside in varicella infection of compromised hosts. J Pediatr 81: 562–565, 1972
20. Juel-Jensen BE, MacCallum FO: Herpes Simplex, Varicella and Zoster: Clinical manifestations and treatment. Philadelphia, JB Lippincott Company, 1972
21. Kraybill EN, Sever JL, Avery GB: Experimental use of cytosine arabinoside in congenital cytomegalovirus infection. J Pediatr 80: 485–487, 1972
22. McCracken GH Jr, Luby JP: Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease. J Pediatr 80: 488–495, 1972
23. VanDersarl JV, Davis CM, Fenton RM: Cytosine arabinoside therapy for herpes zoster in a patient with systemic lupus erythematosus. South Med J 65: 995–997, 1972
24. Fortuny IE, Weiss R, Theologides A: Cytosine arabinoside in herpes zoster. Lancet 1: 38, 1973
25. Davis CM, VanDersarl JV, Coltman CA: Failure of cytarabine in varicella–zoster infections. JAMA 224: 122–123, 1973
26. Juel-Jensen BE: Herpes simplex and zoster. Br Med J 1: 406–410, 1973
27. Pierce LE, Jenkins RB: Herpes zoster ophthalmicus treated with cytarabine. Arch Ophthalmol 89: 21–24, 1973
28. Wilfert CM: Disseminated varicella in a patient with leukemia. J Pediatr 79: 172–173, 1971
29. Mitchell MS, Wade ME, DeConti RC: Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med 70: 535–547, 1969
30. Stevens DA, Merigan TC: Interferon, antibody, and other host factors in herpes zoster. J Clin Invest 51: 1170–1178, 1972
31. Rapp F: Inhibition by metabolic analogues of plaque formation by herpes zoster and herpes simplex viruses. J Immunol 93: 643–648, 1964
32. Hanka LJ, Kuentzel SL, Neil GL: Improved microbiological assay for cytosine arabinoside (NSC 63878). Cancer Chemother Rep 54: 393–397, 1970
33. Stevens DA, Merigan TC: Herpes zoster: recent studies. Natl Cancer Inst Monogr
34. Ho DHW, Frei E III: Clinical pharmacology of 1-β-D-arabinofuranosyl cytosine. Clin Pharmacol Ther 12: 944–954, 1971
35. Howard JP, Albo V, Newton WA Jr: Cytosine arabinoside: results of a cooperative study in acute childhood leukemia. Cancer 21: 341–345, 1968
36. Ellison RR, Holland JF, Weil M: Arabinosylcytosine, a useful agent in the treatment of acute leukemia in adults. Blood 32: 507–523, 1968